One study performed a meta-analysis which showed that PARP1 mRNA expression was heterogeneous between breast cancer subtypes and was overexpressed in 58% of breast cancers (9); this was concurrent with the results of the present study, which found that PARP1 expression was elevated in patients with IDBC. This evidence concerns the gene PARP1 and breast cancer.